mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |